Clinical Trial Update: Differential Metabolic Effects of Fenofibrate and Fatty Acid [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating differential metabolic effects of fenofibrate versus a fatty acid supplement in individuals with hypertriglyceridemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• Fatty acid (fatty acid)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Hypertriglyceridemia | Phase 4 | Status: COMPLETED